Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Global Hemophilia Market Key Trends, Size, Growth, Shares And Forecast Report 2016

(Medical-NewsWire.com, April 15, 2016 ) Hemophilia refers to a set of hereditary genetic disorders that impairs the body's ability to control blood clotting, which controls bleeding when a blood vessel is broken. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. In the absence of a treatment, uncontrolled internal bleeding can occur, causing stiffness, pain, severe joint damage and even death. Depending upon the coagulation factor deficiency, there are different types of hemophilia such as Hemophilia A, Hemophilia B, Hemophilia C, Von Willebrand disease and Hemophilia with Inhibitors.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=703128

Even though Hemophilia is rare bleeding disorder, the number of people affected by it has been increasing with time. While mild hemophilia is easy to diagnose especially in kids, when they learn to move and walk, and get large bruises from minute falls, severe hemophilia patients need to go for periodic transfusion of the respective factors so as to avoid the event of life-threatening bleeding episodes. Such a periodic transfusion is done through what is commonly known as the replacement therapy. With increasing sophistication and modernization of technology, demand for advanced treatment options increases, thereby making the entire market grow.

The key factors which are anticipated to drive this market include increasing penetration of recombinant factor VIII, increasing healthcare expenditure, emerging use of treatments in low income countries and increasing diagnosis rates. Some of the noteworthy progresses of this industry include the increasing adoption of prophylaxis therapy, introduction of extended half-life products and gene therapy. However, the growth of respective industry is challenged by the high cost of treatments and high reluctance by patients to switch to new treatments/products.

The report provides a comprehensive study of global hemophilia market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. The global hemophilia industry is highly competitive consisting of several large companies including the Shire Plc, Bayer Group, Pfizer Inc, Novo Nordisk etc. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Browse Detail Report With TOC @ http://www.researchmoz.us/global-hemophilia-market-report-2016-edition-report.html

Table of Content

1. Overview
1.1 Types of Hemophilia
1.1.1 Hemophilia A
1.1.2 Hemophilia B
1.1.3 Hemophilia C
1.1.4 Hemophilia with Inhibitors
1.1.5 Von Willebrands Disease
1.2 Signs and Symptoms
1.3 Treatments of Hemophilia
1.3.1 Replacement Therapy

2. Market Analysis
2.1 Global Hemophilia Market
2.1.1 Global Hemophilia Prevalence
2.1.2 Global Hemophilia Diagnosis and Treatment
2.1.3 Global Hemophilia Market Revenue
2.1.4 Global Demand for FVIII for Hemophilia A
2.1.5 Global Supply Capacity of Recombinant FVIII for Hemophilia A
2.1.6 Global Hemophilia A Market Revenue
2.1.7 Global Hemophilia B Market Revenue
2.1.8 Global Hemophilia with Inhibitors Market Revenue
2.2 The US Hemophilia Market
2.2.1The US Hemophilia Patients Treated per Year
2.2.2 The US Hemophilia Market Revenue
2.2.3 The US Hemophilia A Patients Treated per Year
2.2.4 The US Hemophilia A Market Revenue
2.2.5 The US Hemophilia B Patients Treated per Year
2.2.6 The US Hemophilia B Market Revenue
2.2.7 The US Hemophilia with Inhibitors Patients Treated per Year
2.2.8 The US Hemophilia with Inhibitors Market Revenue
2.2.9 The US Von Willebrand Factor Market Revenue
2.3 Europe Hemophilia Market
2.3.1 Europe Hemophilia Patients
2.3.2 Europe Hemophilia A Patients
2.3.3 Europe Hemophilia A Therapy by Severity
2.3.4 Europe Hemophilia B Patients
2.3.5 Europe Hemophilia B Therapy by Severity

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Increasing Penetration of Recombinant FVIII
3.1.2 Increasing Healthcare Expenditures
3.1.3 Emerging Use of Treatments in Low Income Countries
3.1.4 Increasing Diagnosis Rate
3.2 Key Trends
3.2.1 Increasing adoption of Prophylaxis
3.2.2 Gene Therapy
3.2.3 Introduction of Extended Half-Life Products
3.3 Challenges
3.3.1 High Cost of Treatment
3.3.2 Reluctance to Switch to New Treatments/Products

4. Competitive Landscape
4.1 Competition by Market Share
4.1.1 Hemophilia Market Share
4.1.2 Hemophilia A Market Share
4.2 Competition by Financials
4.2.1 Competition by Market Cap
4.2.2 Competition by Profit Margin

5. Company Profiles
5.1 Shire PLC
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Bayer Group
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Novo Nordisk
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
5.4 Pfizer Inc.
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=703128

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease

Researchmoz Global Pvt.Ltd

Researchmoz

+1-518-621-2074

sales@researchmoz.us

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC